Cargando…

Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report

BACKGROUND: Peripheral T-cell lymphoma (PTCL), an aggressive and rare disease that belongs to a heterogeneous group of mature T-cell lymphomas, develops rapidly and has a poor prognosis. Early detection and treatment are essential to improve patient cure and survival rates. Here, we report a rare ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Miao-Miao, Fu, Wen-Jun, Wu, Jia, Zhu, Lin-Lin, Niu, Ting, Yang, Rong, Yao, Jin, Lu, Qiang, Liao, Xiao-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477668/
https://www.ncbi.nlm.nih.gov/pubmed/36159409
http://dx.doi.org/10.12998/wjcc.v10.i26.9417
_version_ 1784790413432848384
author Wu, Miao-Miao
Fu, Wen-Jun
Wu, Jia
Zhu, Lin-Lin
Niu, Ting
Yang, Rong
Yao, Jin
Lu, Qiang
Liao, Xiao-Yang
author_facet Wu, Miao-Miao
Fu, Wen-Jun
Wu, Jia
Zhu, Lin-Lin
Niu, Ting
Yang, Rong
Yao, Jin
Lu, Qiang
Liao, Xiao-Yang
author_sort Wu, Miao-Miao
collection PubMed
description BACKGROUND: Peripheral T-cell lymphoma (PTCL), an aggressive and rare disease that belongs to a heterogeneous group of mature T-cell lymphomas, develops rapidly and has a poor prognosis. Early detection and treatment are essential to improve patient cure and survival rates. Here, we report a rare case of PTCL with clinical presentation of noncirrhotic portal hypertension, which provides a basis for early vigilance of lymphomas in the future. CASE SUMMARY: A 65-year-old Chinese woman was admitted to our hospital because of abdominal distension for 3 months and pitting oedema of both lower limbs for 2 months. Physical examinations and associated auxiliary examinations showed the presence of hepatosplenomegaly, and her hepatic venous pressure gradient was 10 mmHg. Immunohistochemical analysis of the liver biopsy confirmed the diagnosis of PTCL. The patient underwent combination therapy with dexamethasone, VP-16, and chidamide. Unfortunately, after 41 days of chemotherapy, the patient died of multiple organ failure. CONCLUSION: PCTL accompanied by noncirrhotic portal hypertension is rarely reported. This case report discusses the diagnosis of a patient according to the literature.
format Online
Article
Text
id pubmed-9477668
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-94776682022-09-23 Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report Wu, Miao-Miao Fu, Wen-Jun Wu, Jia Zhu, Lin-Lin Niu, Ting Yang, Rong Yao, Jin Lu, Qiang Liao, Xiao-Yang World J Clin Cases Case Report BACKGROUND: Peripheral T-cell lymphoma (PTCL), an aggressive and rare disease that belongs to a heterogeneous group of mature T-cell lymphomas, develops rapidly and has a poor prognosis. Early detection and treatment are essential to improve patient cure and survival rates. Here, we report a rare case of PTCL with clinical presentation of noncirrhotic portal hypertension, which provides a basis for early vigilance of lymphomas in the future. CASE SUMMARY: A 65-year-old Chinese woman was admitted to our hospital because of abdominal distension for 3 months and pitting oedema of both lower limbs for 2 months. Physical examinations and associated auxiliary examinations showed the presence of hepatosplenomegaly, and her hepatic venous pressure gradient was 10 mmHg. Immunohistochemical analysis of the liver biopsy confirmed the diagnosis of PTCL. The patient underwent combination therapy with dexamethasone, VP-16, and chidamide. Unfortunately, after 41 days of chemotherapy, the patient died of multiple organ failure. CONCLUSION: PCTL accompanied by noncirrhotic portal hypertension is rarely reported. This case report discusses the diagnosis of a patient according to the literature. Baishideng Publishing Group Inc 2022-09-16 2022-09-16 /pmc/articles/PMC9477668/ /pubmed/36159409 http://dx.doi.org/10.12998/wjcc.v10.i26.9417 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Case Report
Wu, Miao-Miao
Fu, Wen-Jun
Wu, Jia
Zhu, Lin-Lin
Niu, Ting
Yang, Rong
Yao, Jin
Lu, Qiang
Liao, Xiao-Yang
Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report
title Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report
title_full Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report
title_fullStr Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report
title_full_unstemmed Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report
title_short Noncirrhotic portal hypertension due to peripheral T-cell lymphoma, not otherwise specified: A case report
title_sort noncirrhotic portal hypertension due to peripheral t-cell lymphoma, not otherwise specified: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477668/
https://www.ncbi.nlm.nih.gov/pubmed/36159409
http://dx.doi.org/10.12998/wjcc.v10.i26.9417
work_keys_str_mv AT wumiaomiao noncirrhoticportalhypertensionduetoperipheraltcelllymphomanototherwisespecifiedacasereport
AT fuwenjun noncirrhoticportalhypertensionduetoperipheraltcelllymphomanototherwisespecifiedacasereport
AT wujia noncirrhoticportalhypertensionduetoperipheraltcelllymphomanototherwisespecifiedacasereport
AT zhulinlin noncirrhoticportalhypertensionduetoperipheraltcelllymphomanototherwisespecifiedacasereport
AT niuting noncirrhoticportalhypertensionduetoperipheraltcelllymphomanototherwisespecifiedacasereport
AT yangrong noncirrhoticportalhypertensionduetoperipheraltcelllymphomanototherwisespecifiedacasereport
AT yaojin noncirrhoticportalhypertensionduetoperipheraltcelllymphomanototherwisespecifiedacasereport
AT luqiang noncirrhoticportalhypertensionduetoperipheraltcelllymphomanototherwisespecifiedacasereport
AT liaoxiaoyang noncirrhoticportalhypertensionduetoperipheraltcelllymphomanototherwisespecifiedacasereport